- Home
- XOM vs ABBV Comparison
XOM vs ABBV Comparison
Compare XOM & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XOM | ABBV |
|---|---|---|
| Founded | 1870 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 480.5B | 394.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XOM | ABBV |
|---|---|---|
| Price | $116.93 | $226.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 18 |
| Target Price | $130.74 | ★ $242.28 |
| AVG Volume (30 Days) | ★ 15.1M | 5.5M |
| Earning Date | 01-30-2026 | 01-30-2026 |
| Dividend Yield | ★ 3.47% | 3.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.89 | 1.32 |
| Revenue | ★ $326,245,000,000.00 | $59,644,000,000.00 |
| Revenue This Year | N/A | $10.37 |
| Revenue Next Year | $0.19 | $9.41 |
| P/E Ratio | ★ $17.25 | $169.10 |
| Revenue Growth | N/A | ★ 7.40 |
| 52 Week Low | $97.80 | $164.39 |
| 52 Week High | $120.81 | $244.81 |
Technical Indicators
Market Signals| Indicator | XOM | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 49.87 |
| Support Level | $115.04 | $221.10 |
| Resistance Level | $120.36 | $225.98 |
| Average True Range (ATR) | 2.04 | 4.22 |
| MACD | 0.07 | -0.52 |
| Stochastic Oscillator | 45.22 | 44.39 |
Price Performance
Historical ComparisonAbout XOM Exxon Mobil Corporation
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2024, it produced 3.0 million barrels of liquids and 8.1 billion cubic feet of natural gas per day. At the end of 2024, reserves were 19.9 billion barrels of oil equivalent, 69% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.3 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.